Sign in
Home
News
About Us
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Knox Daily
Opinion Matters
Home
News
About Us
Contact Us
Home
Tags
Revance Therapeutics Inc.
Tag: Revance Therapeutics Inc.
Stock Earnings
Taking a look at what insiders are doing to gauge the Revance Therapeutics Inc. (RVNC)’s direction
Samantha Gray
-
March 17, 2023
0
Insiders Updates
Investing in Revance Therapeutics Inc. (RVNC) Is Getting More Attractive
Roman Campbell
-
March 14, 2023
0
Analysts Viewpoint
CEO Foley Mark J sold 70,390 shares of Revance Therapeutics Inc. [RVNC]
Anna Perez
-
March 10, 2023
0
Stock Earnings
Revance Therapeutics Inc. [RVNC] stock was sold by Schilke Tobin at the price of US$0.11 million
Samantha Gray
-
March 7, 2023
0
Insiders Updates
Selling Buzz: Revance Therapeutics Inc. [RVNC] CFO Schilke Tobin sells 3,201 shares of the company
Samantha Gray
-
March 3, 2023
0
Analysts Viewpoint
Revance Therapeutics Inc. [RVNC] CFO sales 3,201 shares for $0.11 million.
Samantha Gray
-
February 28, 2023
0
![CEO Foley Mark J sold 70,390 shares of Revance Therapeutics Inc. [RVNC]](https://knoxdaily.com/wp-content/uploads/2020/09/pexels-karolina-grabowska-4386431.jpg "CEO Foley Mark J sold 70,390 shares of Revance Therapeutics Inc. [RVNC]")
![Revance Therapeutics Inc. [RVNC] stock was sold by Schilke Tobin at the price of US$0.11 million](https://knoxdaily.com/wp-content/uploads/2020/08/house-1353389_640.jpg "Revance Therapeutics Inc. [RVNC] stock was sold by Schilke Tobin at the price of US$0.11 million")
![Selling Buzz: Revance Therapeutics Inc. [RVNC] CFO Schilke Tobin sells 3,201 shares of the company](https://knoxdaily.com/wp-content/uploads/2020/10/Image-82.png "Selling Buzz: Revance Therapeutics Inc. [RVNC] CFO Schilke Tobin sells 3,201 shares of the company")
![Revance Therapeutics Inc. [RVNC] CFO sales 3,201 shares for $0.11 million.](https://knoxdaily.com/wp-content/uploads/2020/09/equalizer-255396_640.jpg "Revance Therapeutics Inc. [RVNC] CFO sales 3,201 shares for $0.11 million.")